Found 553 clinical trials
Study of Combination Therapy for the Treatment of Adults with Post-Traumatic Stress Disorder
If you’ve experienced or witnessed a traumatic event and now have unwanted memories of the event, struggle with fear and anxiety, feel isolated from family and friends, or avoid situations that remind you of the trauma, you may have post-traumatic stress disorder (PTSD).
- 83 views
- 21 Apr, 2021
- 1 location
A Phase 3, Multicenter, Randomized, Double-blind Trial of Fixed-Dose Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Posttraumatic Stress Disorder
Brexpiprazole is a medication being studied as a possible adjunctive treatment for post-traumatic stress disorder (PTSD). The medication was first approved in the United States for the treatment of schizophrenia and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.Otsuka is conducting this study to find …
- 0 views
- 06 Apr, 2021
- 1 location
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies
The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390 + INCMGA00012.
- 0 views
- 04 Aug, 2020
- 3 locations
Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease
Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease
- 853 views
- 23 Nov, 2020
- 3 locations
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies
- 448 views
- 25 Aug, 2021
- 11 locations
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1 - 3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1 - 3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post
- 1396 views
- 25 Mar, 2021
- 1 location
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Liver Transplant
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Liver Transplant
- 444 views
- 08 Nov, 2020
- 1 location
Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)
Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)
- 1055 views
- 25 Mar, 2021
- 1 location
Clinical study seeking patients with PTSD
Clinical study seeking patients with PTSD
- 2041 views
- 25 Mar, 2021
- 1 location
Azole-echinocandin Combination Therapy for Invasive Aspergillosis
outcome is of patients that turn out to be infected with a triazole resistant A. fumigatus who started with a triazole-echinocandin combination therapy.
- 0 views
- 16 Oct, 2021
- 4 locations